387 related articles for article (PubMed ID: 14674000)
21. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS
Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638
[TBL] [Abstract][Full Text] [Related]
22. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
23. Effects of monomethylfumarate on dendritic cell differentiation.
Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
[TBL] [Abstract][Full Text] [Related]
24. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18.
Tucci M; Quatraro C; Lombardi L; Pellegrino C; Dammacco F; Silvestris F
Arthritis Rheum; 2008 Jan; 58(1):251-62. PubMed ID: 18163476
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus.
Dieker JW; Fransen JH; van Bavel CC; Briand JP; Jacobs CW; Muller S; Berden JH; van der Vlag J
Arthritis Rheum; 2007 Jun; 56(6):1921-33. PubMed ID: 17530637
[TBL] [Abstract][Full Text] [Related]
27. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
Li CD; Zhang WY; Yuan CL; Han LY
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165
[TBL] [Abstract][Full Text] [Related]
28. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L
J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930
[TBL] [Abstract][Full Text] [Related]
29. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
Toubi E; Kessel A; Shoenfeld Y
Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
[TBL] [Abstract][Full Text] [Related]
30. Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease.
Becker BN; Fuchs H; Hakim R
J Am Soc Nephrol; 1995 Apr; 5(10):1746-50. PubMed ID: 7787141
[TBL] [Abstract][Full Text] [Related]
31. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
32. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
[TBL] [Abstract][Full Text] [Related]
33. Prolactin, dendritic cells, and systemic lupus erythematosus.
Jara LJ; Benitez G; Medina G
Autoimmun Rev; 2008 Jan; 7(3):251-5. PubMed ID: 18190887
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients.
Köller M; Zwölfer B; Steiner G; Smolen JS; Scheinecker C
Int Immunol; 2004 Nov; 16(11):1595-604. PubMed ID: 15381672
[TBL] [Abstract][Full Text] [Related]
35. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
Arthritis Rheum; 2000 Sep; 43(9):1976-81. PubMed ID: 11014347
[TBL] [Abstract][Full Text] [Related]
37. Treatment of murine lupus using nucleosomal T cell epitopes identified by bone marrow-derived dendritic cells.
Suen JL; Chuang YH; Tsai BY; Yau PM; Chiang BL
Arthritis Rheum; 2004 Oct; 50(10):3250-9. PubMed ID: 15476240
[TBL] [Abstract][Full Text] [Related]
38. Immune modulation of human dendritic cells by complement.
Castellano G; Woltman AM; Schlagwein N; Xu W; Schena FP; Daha MR; van Kooten C
Eur J Immunol; 2007 Oct; 37(10):2803-11. PubMed ID: 17899552
[TBL] [Abstract][Full Text] [Related]
39. The maturation-dependent production of interleukin-16 is impaired in monocyte-derived dendritic cells from atopic dermatitis patients but is restored by inflammatory cytokines TNF-alpha and IL-1beta.
Reich K; Hugo S; Middel P; Blaschke V; Heine A; Neumann C
Exp Dermatol; 2004 Dec; 13(12):740-7. PubMed ID: 15560757
[TBL] [Abstract][Full Text] [Related]
40. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor.
Liu CC; Wang YS; Lin CY; Chuang TF; Liao KW; Chi KH; Chen MF; Chiang HC; Chu RM
Cancer Immunol Immunother; 2008 Apr; 57(4):479-91. PubMed ID: 17710396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
